España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Henry Schein
HSIC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$73.22
1.47
2.05%
At close: -
$73.22
0.00
0.00%
After Hours: Jan 17, 4:25 PM EDT
Get Report
Comment
Acentus was acquired by Henry Schein (HSIC) on Wednesday, January 15, 2025
Henry Schein (HSIC) Forecast
News
Earnings
Henry Schein (HSIC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Henry Schein (NASDAQ:HSIC) Stock
Henry Schein Stock (NASDAQ: HSIC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 07, 2025
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst
Vandana Singh
Monday, January 06, 2025
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
B of A Securities Upgrades Henry Schein to Bu...
Benzinga Newsdesk
Tuesday, December 17, 2024
How Is The Market Feeling About Henry Schein?
Benzinga Insights
Thursday, December 12, 2024
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
Vandana Singh
Wednesday, December 04, 2024
The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts
Benzinga Insights
Mizuho Initiates Coverage On Henry Schein wit...
Benzinga Newsdesk
Wednesday, November 20, 2024
Peering Into Henry Schein's Recent Short Interest
Benzinga Insights
Henry Schein Signed An Agreement To Acquire A...
Benzinga Newsdesk
Monday, November 18, 2024
Henry Schein shares are trading higher. The s...
Benzinga Newsdesk
Activist Investor Ananym Capital Pushes For C...
Benzinga Newsdesk
Wednesday, November 06, 2024
Analyst Ratings For Henry Schein
Benzinga Insights
Barrington Research Maintains Outperform on H...
Benzinga Newsdesk
Tuesday, November 05, 2024
Henry Schein Q3 Earnings: Sees Recovery From Cyber Incident, Says Dental Equipment Business Shows Stability In North America
Vandana Singh
Henry Schein Expects 2024 Adjusted EPS Of $4....
Benzinga Newsdesk
Henry Schein Q3 2024 Adj EPS $1.22 Beats $1.1...
Benzinga Newsdesk
Tuesday, October 08, 2024
Where Henry Schein Stands With Analysts
Benzinga Insights
Evercore ISI Group Maintains In-Line on Henry...
Benzinga Newsdesk
Friday, September 20, 2024
Barrington Research Maintains Outperform on H...
Benzinga Newsdesk
Tuesday, September 17, 2024
Henry Schein Reaches Agreement With Swiss Com...
Benzinga Newsdesk
Tuesday, September 10, 2024
Sell Alert: Lorelei McGlynn Cashes Out $1.46M In Henry Schein Stock
Benzinga Insights
Friday, August 16, 2024
Henry Schein EVP Sold $207K In Company Stock
Benzinga Insights
Monday, August 12, 2024
JP Morgan Maintains Overweight on Henry Schei...
Benzinga Newsdesk
Wednesday, August 07, 2024
UBS Maintains Neutral on Henry Schein, Lowers...
Benzinga Newsdesk
Baird Maintains Outperform on Henry Schein, L...
Benzinga Newsdesk
Evercore ISI Group Maintains In-Line on Henry...
Benzinga Newsdesk
Forecasting The Future: 5 Analyst Projections For Henry Schein
Benzinga Insights
Barrington Research Maintains Outperform on H...
Benzinga Newsdesk
Tuesday, August 06, 2024
Dental Equipment Distributor Henry Schein Reports Mixed Q2 Earnings, Cuts Guidance And Warns Slower Recovery From Cyberattack
Vandana Singh
Henry Schein shares are trading lower after t...
Benzinga Newsdesk
Henry Schein Sees FY24 Adj. EPS $4.70-$4.82 V...
Benzinga Newsdesk
Henry Schein Q2 2024 Adj EPS $1.23 Beats $1.2...
Benzinga Newsdesk
Monday, August 05, 2024
What's in Store for These 3 MedTech Stocks in Q2 Earnings?
Zacks
Monday, July 29, 2024
Henry Schein Has Acquired abc dental AG, A Fu...
Benzinga Newsdesk
Monday, July 22, 2024
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Analyst Expectations For Henry Schein's Future
Benzinga Insights
Baird Upgrades Henry Schein to Outperform, Ra...
Benzinga Newsdesk
Tuesday, July 09, 2024
Evercore ISI Group Maintains In-Line on Henry...
Benzinga Newsdesk
Friday, July 05, 2024
Breaking Down Henry Schein: 4 Analysts Share Their Views
Benzinga Insights
Barrington Research Maintains Outperform on H...
Benzinga Newsdesk
Tuesday, June 25, 2024
Looking Into Henry Schein's Recent Short Interest
Benzinga Insights
Henry Schein Says Its Unit Biohorizons Releas...
Benzinga Newsdesk
Friday, June 21, 2024
Piper Sandler Reiterates Overweight on Henry ...
Benzinga Newsdesk
Wednesday, May 29, 2024
Peering Into Henry Schein's Recent Short Interest
Benzinga Insights
Monday, May 13, 2024
Looking Into Henry Schein's Recent Short Interest
Benzinga Insights
Wednesday, May 08, 2024
Barrington Research Maintains Outperform on H...
Benzinga Newsdesk
Expert Outlook: Henry Schein Through The Eyes Of 7 Analysts
Benzinga Insights
UBS Maintains Neutral on Henry Schein, Lowers...
Benzinga Newsdesk
Tuesday, May 07, 2024
Dental Supplies Distributor Henry Schein's Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
Vandana Singh
Henry Schein Expects 2024 Sales Growth Of App...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
